DocGo Inc. (NASDAQ:DCGO) Short Interest Update

DocGo Inc. (NASDAQ:DCGO - Get Free Report) was the recipient of a significant decrease in short interest in May. As of May 15th, there was short interest totalling 5,190,000 shares, a decrease of 20.3% from the April 30th total of 6,510,000 shares. Based on an average daily volume of 1,230,000 shares, the days-to-cover ratio is presently 4.2 days. Approximately 6.0% of the company's stock are sold short.

DocGo Trading Down 0.7%

DCGO stock traded down $0.01 during mid-day trading on Tuesday, hitting $1.48. 640,283 shares of the company were exchanged, compared to its average volume of 793,669. The stock has a market capitalization of $150.93 million, a PE ratio of 5.29, a price-to-earnings-growth ratio of 14.16 and a beta of 1.14. The business has a 50 day simple moving average of $2.05 and a 200-day simple moving average of $3.42. DocGo has a 1-year low of $1.23 and a 1-year high of $5.68.

DocGo (NASDAQ:DCGO - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.08). The business had revenue of $96.03 million for the quarter, compared to analyst estimates of $104.25 million. DocGo had a return on equity of 8.90% and a net margin of 4.35%. Equities research analysts expect that DocGo will post 0.25 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the stock. Stifel Nicolaus cut their price target on shares of DocGo from $6.50 to $5.50 and set a "buy" rating for the company in a report on Friday, February 28th. BTIG Research lowered DocGo from a "buy" rating to a "neutral" rating in a research report on Friday, May 9th. Canaccord Genuity Group restated a "hold" rating and issued a $1.45 target price (down previously from $5.00) on shares of DocGo in a research note on Monday, May 12th. Needham & Company LLC reduced their price target on shares of DocGo from $4.00 to $3.00 and set a "buy" rating for the company in a report on Friday, May 9th. Finally, Deutsche Bank Aktiengesellschaft downgraded DocGo from a "buy" rating to a "hold" rating and cut their target price for the stock from $5.00 to $2.85 in a research report on Friday, February 28th. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $3.56.

Institutional Trading of DocGo

Several institutional investors and hedge funds have recently bought and sold shares of the company. Summit Securities Group LLC purchased a new position in shares of DocGo in the first quarter valued at about $34,000. Summit Investment Advisors Inc. lifted its position in DocGo by 38.7% during the fourth quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company's stock valued at $45,000 after purchasing an additional 2,968 shares during the period. Prudential Financial Inc. purchased a new stake in shares of DocGo during the 4th quarter valued at about $55,000. Royce & Associates LP bought a new position in shares of DocGo during the 4th quarter valued at approximately $64,000. Finally, Strs Ohio bought a new position in shares of DocGo in the first quarter worth about $76,000. 56.44% of the stock is currently owned by hedge funds and other institutional investors.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.